Vertex Ventures HC Leads Series B in Bicycle Therapeutics

On June 1, 2017, Bicycle Therapeutics, a U.K.-based biotherapeutics company, raised £40 million in Series B funding. Leading the investment round was Vertex Ventures HC, a venture unit of Temasek Holdings. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute

institutional investor investment mandates